Admedus is focused on developing the very latest vaccine technology.

Our scientific team is focused on developing new technologies that have high global demand with  the potential to improve the quality of life for patients around the world


Our next generation vaccine technology builds on the novel scientific information discovered, published and patented from Professor Ian Frazer’s work that led to the development of Gardasil® – the first prophylactic cervical cancer vaccine.

Admedus technology is particularly effective in stimulating cellular immune responses that have an enhanced ability to destroy infected or cancerous cells.